News

Biological E partners with China’s Recbio to produce REC603 a 9-valent HPV vaccine in India The collaboration aims to expand ...
Biological E will begin large-scale manufacturing of the HPV9 vaccine once the Technology transfer is completed.
Nagpur: \"HPV vaccines are not only for girls. boys from 9 to 26 years of age should also take them. HPV isn't just about ...
Oncologists in India warn of rising HPV-related cancers in young adults, stressing the need for urgent prevention measures.
A growing number of oncologists across India have expressed concern over Human Papillomavirus (HPV) becoming a major ...
The implementation of these three key pillars — vaccination, screening, and treatment — are critical in eliminating cervical ...
Experts calls for HPV vaccination and screening in India to combat rising cervical, oral, and throat cancers among young ...
Low screening coverage, late diagnoses, high HIV prevalence, and limited access to treatment and vaccines are driving cervical cancer cases and deaths in South Africa. The country has a cervical ...
According to the agreement, BE will receive the exclusive right to commercialise the vaccine in India and participate in ...
The US Secretary of Health and Human Services insists he will soon announce the "cause" of autism, but setting a fixed ...
While HPV is the leading cause of cervical cancer, lifestyle, immunity, and reproductive factors also play a major role — ...
The screening test checks for the presence of the human papillomavirus or HPV. Some types of HPV can cause changes in the ...